Clinical implications of using molecular diagnostics for ovarian cancers.
about
The MAPK pathway across different malignancies: a new perspective.Modeling the Dynamics of High-Grade Serous Ovarian Cancer Progression for Transvaginal Ultrasound-Based Screening and Early DetectionOvarian cancer treatment: The end of empiricism?Characteristics of 10-year survivors of high-grade serous ovarian carcinoma.Mathematical models of breast and ovarian cancers.Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC.
P2860
Clinical implications of using molecular diagnostics for ovarian cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical implications of using molecular diagnostics for ovarian cancers.
@en
Clinical implications of using molecular diagnostics for ovarian cancers.
@nl
type
label
Clinical implications of using molecular diagnostics for ovarian cancers.
@en
Clinical implications of using molecular diagnostics for ovarian cancers.
@nl
prefLabel
Clinical implications of using molecular diagnostics for ovarian cancers.
@en
Clinical implications of using molecular diagnostics for ovarian cancers.
@nl
P2093
P2860
P356
P1433
P1476
Clinical implications of using molecular diagnostics for ovarian cancers.
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDT464
P478
24 Suppl 10
P577
2013-12-01T00:00:00Z